Jill Beraud

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill Beraud:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEVI STRAUSS & CO Director Class A Common Stock 181,157 $3,349,592 $18.49 22 Apr 2026 Direct
LEVI STRAUSS & CO Director Class B Common Stock 14,285 $2,197,734 $17.93 25 Feb 2026 Direct
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23,458 01 May 2024 Direct

Insider Reports Filed by Jill Beraud

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LEVI LEVI STRAUSS & CO 22 Apr 2026 1 $0 4 Director 24 Apr 2026, 16:30
LEVI LEVI STRAUSS & CO 25 Feb 2026 2 $0 4 Director 27 Feb 2026, 17:06
LEVI LEVI STRAUSS & CO 04 Nov 2025 2 $0 4 Director 06 Nov 2025, 16:14
LEVI LEVI STRAUSS & CO 08 Aug 2025 2 $0 4 Director 12 Aug 2025, 16:53
LEVI LEVI STRAUSS & CO 09 May 2025 2 $0 4 Director 12 May 2025, 21:57
LEVI LEVI STRAUSS & CO 23 Apr 2025 3 $0 4 Director 25 Apr 2025, 16:19
LEVI LEVI STRAUSS & CO 28 Feb 2025 2 $0 4 Director 04 Mar 2025, 16:47
/report/000095017025015341-beraud-jill-2025-02-04 Revance Therapeutics, Inc. 04 Feb 2025 2 -$104,412 4 Director 06 Feb 2025, 15:49
LEVI LEVI STRAUSS & CO 14 Nov 2024 2 $0 4 Director 18 Nov 2024, 16:52
LEVI LEVI STRAUSS & CO 20 Aug 2024 2 $0 4 Director 22 Aug 2024, 20:46
LEVI LEVI STRAUSS & CO 23 May 2024 2 $0 4 Director 28 May 2024, 17:33
/report/000147929024000084-beraud-jill-2024-05-01 Revance Therapeutics, Inc. 01 May 2024 2 $0 4 Director 03 May 2024, 08:42
LEVI LEVI STRAUSS & CO 24 Apr 2024 1 $0 4 Director 26 Apr 2024, 20:59
LEVI LEVI STRAUSS & CO 23 Feb 2024 2 $0 4 Director 27 Feb 2024, 18:24
LEVI LEVI STRAUSS & CO 09 Nov 2023 2 $0 4 Director 13 Nov 2023, 20:44
LEVI LEVI STRAUSS & CO 17 Aug 2023 2 $0 4 Director 21 Aug 2023, 18:33
LEVI LEVI STRAUSS & CO 18 May 2023 2 $0 4 Director 22 May 2023, 20:58
/report/000147929023000058-beraud-jill-2023-05-03 Revance Therapeutics, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 17:13
LEVI LEVI STRAUSS & CO 19 Apr 2023 1 $0 4 Director 21 Apr 2023, 18:39
LEVI LEVI STRAUSS & CO 23 Feb 2023 2 $0 4 Director 27 Feb 2023, 20:56
LEVI LEVI STRAUSS & CO 21 Nov 2022 1 $0 4 Director 23 Nov 2022, 15:06
LEVI LEVI STRAUSS & CO 17 Aug 2022 1 $0 4 Director 18 Aug 2022, 16:23
LEVI LEVI STRAUSS & CO 24 May 2022 1 $0 4 Director 25 May 2022, 18:34
/report/000147929022000065-beraud-jill-2022-05-04-restatement Revance Therapeutics, Inc. 04 May 2022 1 $0 4/A Director 13 May 2022, 18:08
LEVI LEVI STRAUSS & CO 20 Apr 2022 1 $0 4 Director 22 Apr 2022, 16:05
LEVI LEVI STRAUSS & CO 24 Feb 2022 1 $0 4 Director 28 Feb 2022, 15:34
LEVI LEVI STRAUSS & CO 17 Nov 2021 1 $0 4 Director 18 Nov 2021, 16:03
LEVI LEVI STRAUSS & CO 18 Aug 2021 1 $0 4 Director 02 Sep 2021, 17:16
LEVI LEVI STRAUSS & CO 15 Jul 2021 1 $0 4 Director 19 Jul 2021, 21:16
LEVI LEVI STRAUSS & CO 25 May 2021 1 $0 4 Director 26 May 2021, 20:20
/report/000147929021000106-beraud-jill-2021-05-05 Revance Therapeutics, Inc. 05 May 2021 2 $0 4 Director 07 May 2021, 19:04
LEVI LEVI STRAUSS & CO 25 Mar 2019 4 $0 4/A Director 21 Apr 2023, 18:20
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .